Essential thrombocytosis risk factors: Difference between revisions
Jump to navigation
Jump to search
Sergekorjian (talk | contribs) No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Common risk factors in the development of essential thrombocytosis are | Common risk factor in the development of essential thrombocytosis is female sex. Common risk factors in the development of thrombotic complications in patients with essential thrombocytosis are previous history of thrombotic events and age greater than 60 years.<ref name="pmid21106990">{{cite journal| author=Beer PA, Erber WN, Campbell PJ, Green AR| title=How I treat essential thrombocythemia. | journal=Blood | year= 2011 | volume= 117 | issue= 5 | pages= 1472-82 | pmid=21106990 | doi=10.1182/blood-2010-08-270033 | pmc=PMC3145107 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21106990 }} </ref> | ||
==Risk factors== | ==Risk factors== | ||
*Most common risk factor in the development of essential thrombocytosis is | *Most common risk factor in the development of essential thrombocytosis is female sex. There is a two fold increased risk in female individuals.<ref name="pmid21106990">{{cite journal| author=Beer PA, Erber WN, Campbell PJ, Green AR| title=How I treat essential thrombocythemia. | journal=Blood | year= 2011 | volume= 117 | issue= 5 | pages= 1472-82 | pmid=21106990 | doi=10.1182/blood-2010-08-270033 | pmc=PMC3145107 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21106990 }} </ref> Most patients remain undiagnosed for a long time. | ||
* | *Risk factors for thrombotic events in patients with essential thrombocytosis may include:<ref name="pmid21106990">{{cite journal| author=Beer PA, Erber WN, Campbell PJ, Green AR| title=How I treat essential thrombocythemia. | journal=Blood | year= 2011 | volume= 117 | issue= 5 | pages= 1472-82 | pmid=21106990 | doi=10.1182/blood-2010-08-270033 | pmc=PMC3145107 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21106990 }} </ref> | ||
**Previous history of thrombotic events | **Previous history of thrombotic events | ||
** | **Age greater than 60 years | ||
==References== | ==References== | ||
Revision as of 18:43, 23 December 2015
|
Essential thrombocytosis Microchapters |
|
Differentiating Essential thrombocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Essential thrombocytosis risk factors On the Web |
|
American Roentgen Ray Society Images of Essential thrombocytosis risk factors |
|
Risk calculators and risk factors for Essential thrombocytosis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Soujanya Thummathati, MBBS [2]
Overview
Common risk factor in the development of essential thrombocytosis is female sex. Common risk factors in the development of thrombotic complications in patients with essential thrombocytosis are previous history of thrombotic events and age greater than 60 years.[1]
Risk factors
- Most common risk factor in the development of essential thrombocytosis is female sex. There is a two fold increased risk in female individuals.[1] Most patients remain undiagnosed for a long time.
- Risk factors for thrombotic events in patients with essential thrombocytosis may include:[1]
- Previous history of thrombotic events
- Age greater than 60 years
References
- ↑ 1.0 1.1 1.2 Beer PA, Erber WN, Campbell PJ, Green AR (2011). "How I treat essential thrombocythemia". Blood. 117 (5): 1472–82. doi:10.1182/blood-2010-08-270033. PMC 3145107. PMID 21106990.